Story perspectives

ARPA-H Reports Promising Osteoarthritis Advances, Human Trials Ahead

4/7/2026

Summary

Story summary

Advanced Research Projects Agency for Health (ARPA-H) announced promising osteoarthritis developments affecting 32 million Americans.
Three years after launching a project, ARPA-H reported progress by teams from Duke University, the University of Colorado, and Columbia University.
Teams are pursuing injections and infusions to regrow bone and cartilage for various joints.
Testing has occurred only in animals, and experts call findings hugely promising, with human trials to begin within 18 months.

1 of 1

Story summary

Advanced Research Projects Agency for Health (ARPA-H) announced promising osteoarthritis developments affecting 32 million Americans.
Three years after launching a project, ARPA-H reported progress by teams from Duke University, the University of Colorado, and Columbia University.
Teams are pursuing injections and infusions to regrow bone and cartilage for various joints.
Testing has occurred only in animals, and experts call findings hugely promising, with human trials to begin within 18 months.